Generic drug

Kelo vs City of New London Kelo v. City of New London case involved the of abuse eminent domain by transferring land from one private owner to another (private owner) in the name of economic development. The case was judged by the Supreme Court of the United States. The Court decided that private redevelopment plans can be considered "public use" under the Takings Clause of the Fifth Amendment as they benefited the general community because of economic growth qualified as a permissible. The…

for the more interesting topic, Slingshot Insights will interview an expert and post a transcript. Option 1: Evaluating the chances of approval and market potential for ALD403, TEV-48125, and AMG 334. Who can win approval and what role will these drugs play? Option 2: Discussing growth prospects for Keryx’s Auryxia after a positive Phase III data readout. Will an expanded indication change the perception of the iron black box warning for physicians? SLINGSHOT CONTRIBUTOR: Phil Loria This…

changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration. The way…

The pharmaceutical industry has an issue that has been ongoing for years. The price of drugs are outrageous. Drug prices are unregulated and a lot of Americans are unaware of what pharmaceuticals do. They control the pricing of drugs that are prescribed to patients. In recent articles written by Andrew Pollack from The New York Times and Heather Long from CNN Wire, they discuss a similar topic but provide their information gathered from different perspectives. One takes the issue on whether it…

to people's health and we are dedicated to people’s genuine smile’’. Actually, Towa has dealt with generic drugs since 1965 under Towa’s philosophy as professional manufacturer of generic drugs. Generic drugs have the same efficacy and safety profile with original drugs so that generic drugs can contribute healthcare and society via inexpensive drug usage. The idea to provide good quality, lower drug price will contribute to healthcare and society. Towa’s philosophy is to value the "smile’ for…

every year. People with a need for EpiPens must find a way to pay the $600 for them when they expire each year. The dramatic increase in price is due to the monopoly that EpiPen has over the industry of epinephrine. After a company creates a unique drug, it is issued a patent that prevents any other sellers from entering the industry, giving the single company the power to charge whatever price that they see fit. Patents give pharmaceutical companies monopolies…

product market level, companies have been forced to compete in terms of original brands and generic drugs. In markets targeting price sensitive customers, generic drugs are generally preferred. By contrast, other company products compete based on efficacy, safety, and compliance by patients in markets that are not price sensitive. Most pharmaceutical companies patent their products to safeguard against generic products that could potentially drive down their prices and reduce their return on…

The pharmaceutical and medications industry regarding the amount of time and money invested in developing new drugs is one of the fastest growing industries in the United States. There are always a lot of researches, developments, and productions of new drugs in the industry of pharmaceutical; however, patients are able to find or get the medications either over the counter in a retail stores, pharmacies, and many other medical markets or by prescriptions. Consequently, medication usage is to…

Americans use more prescription drugs than any other developed country. Prescription drugs only represent 12 percent of total health care costs in the United States, but the rising prices of those drugs is an issue that keeps reoccurring not only for patients, but for prescribers, payers, and policy makers. There are people that believe that the rise in price of these drugs is appropriate, but if they keep on rising in price, the United States will start suffering not only financially but…

48 However, the Bayh-Dole Act has resulted in direct institutional ownership of parts of the intellectual property that protects many new drugs.49 To justify granting these private patent rights for government-sponsored inventions, one cannot use the typical innovation incentive of patents, because academic researchers have been innovating long before the Bayh-Dole Act and are primarily motivated…